Full-Time
Vessel Service Technician
Posted on 7/15/2025
ABEC
501-1,000 employees
Integrated bioprocessing equipment and services.
No salary listed
Goldsboro, NC, USA
In Person
Up to 80% travel required, including domestic and international.
 Mechanical Engineering (2) |
|---|
| , |
- High School diploma or equivalent
- 2 years post high school in equipment service or manufacturing craftsman.
- Experience in welding fabrication & must pass an ASME/PED weld test; experience in grinding and NDT/liquid dye penetrate.
- Experience in reading blueprints
- As much as 90% travel with overnight and extended stay potential.
- Valid driver’s license and passport required/ability to obtain.
- Domestic and international travel is required.
- Able to lift a minimum of 50 lbs. / 23 kilograms
- Typical work is in a manufacturing environment or customer’s site
- Required to stand for long periods of time and may involve heavy manual labor.
- You will need to be able to stand, sit, walk, bend, stoop, reach, lift, push, pull, and carry items.
- Exposure to loud noises
- Ability to wear personal protective equipment
- Ability to communicate with cross-functional team (Vessel Service Managers, Engineering, QA) & ASME Authorized Inspectors.
- Ability to communicate professionally with customers.
- On-site supervising & directing the activities of the Field Technicians.
- Providing leadership in project execution.
- Coordinate tool shipment & return.
- Communication with ASME Authorized Inspectors.
- Assist with “hands-on” Confined Space training for Field Technicians.
- Compliance with all ASME Code & NBIC welding requirements.
- Compliance with customer’s safety SOP’s. Conduct all operations in a safe manner.
- Ability to execute the fabrication scope according to blueprints and specifications.
- Ability to execute other tasks as assigned & recommend improvements.
- Represent company in a respectable way.
- Execute other tasks as assigned
- Ability to travel when required, up to 80% (some local)
ABEC provides integrated biopharmaceutical manufacturing solutions and services. It supports vaccine and antibody production with bioprocess engineering, equipment maintenance, troubleshooting, and repairs, plus design and build of complete bioprocess lines. It offers customized single-use disposable containers, especially Custom Single Run (CSR) products, leveraging 45+ years of design experience. Its goal is to help clients scale manufacturing faster and at lower costs through in-house engineering, global capacity, and long-term partnerships.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Bethlehem, Pennsylvania
Founded
1974
Simplify's Take
What believers are saying
- ABEC's $11M Wilson, NC expansion boosts capacity starting April 2023.
- 5-year warranty on CSR single-use systems enhances client confidence.
- ATB bioreactor launched March 31, 2025, advances ATMP cell therapy production.
What critics are saying
- GOOD Meat counterclaims breach contract, draining resources since March 2023.
- Thermo Fisher undercuts with 0.2L-2000L perfusion systems capturing ATMP clients.
- Sartorius delivers 30% faster single-use containers via German cleanrooms.
What makes ABEC unique
- ABEC's CSR bioreactors enable seamless scale-up from 200L to production matching stainless steel performance.
- ABEC offers largest global biopharma manufacturing with 367,500 ft² and ISO-7 cleanrooms.
- ABEC delivers customized single-use systems exclusively for production-scale bioprocessing over 45 years.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Paid Holidays
Paid Vacation
Medical, dental and vision insurance
Company paid life insurance
401(k) Company Match
401(k) Retirement Plan
College tuition benefit program
Employee Referral Program
Company News
ABEC, a global leader in engineered solutions and services for biotechnology manufacturing, has introduced its Advanced Therapy Bioreactor (ATB(TM), a revolutionary platform focused on transforming cell expansion for Advanced Therapy Medicinal Products (ATMPs).
Eat Just and its cultivated meat subsidiary GOOD Meat have reached an agreement in principle to settle their legal dispute* with bioreactor supplier ABEC, according to court documents, although the matter has not yet reached a final resolution.In a letter to Judge Wendy Beetlestone dated February 6, attorneys for both parties explained that they “have engaged in serious settlement negotiations over the past few months and have reached an agreement in principle regarding the framework for a settlement agreement and the material terms.“However, due to the complex nature of the claims, defenses, and counterclaims,” they added, “the parties require additional time to draft a binding agreement.”In a court order filed on February 7, Judge Beetlestone agreed to their request for the court to appoint a magistrate judge as settlement master to facilitate a final resolution, but rejected their request for a 30-day stay on the litigation and all case deadlines.Neither party has responded to a request for comment from AgFunderNews.What is the case about?The legal dispute began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat of breach of contract by failing to pay its bills on time.According to ABEC, GOOD Meat owed $62,649,231.79 for work ABEC had already completed. Eat Just, in turn, claimed that ABEC had breached the terms of their contract.ABEC, which had been working with GOOD Meat on pilot cultivated chicken facilities in California and Singapore, signed an agreement with the startup in August 2021. Under the seven-year deal, ABEC would design, manufacture, install and commission multiple 250,000-liter vessels— “the largest known bioreactors for avian and mammalian cell culture”—for a large-scale facility in the US.Given “financing hurdles,” by November 2022, Eat Just/GOOD Meat “recommended the evaluation of a phased approach, creating five 125,000-L bioreactors instead of four 250,000-L bioreactors,” and the two started corresponding over amendments to their agreement.By March 2023, ABEC said it had had no choice but to take legal action over unpaid bills. Eat Just/GOOD Meat responded by filing a series of counterclaims, arguing that the parties never formally ratified amendments to their original agreement, and that ABEC had simply proceeded as if they had.Speaking to AgFunderNews last year, Eat Just founder and CEO Josh Tetrick said he was “not attempting to raise money for a large-scale cultivated meat facility right now” and was instead focusing on process development at the firm’s plant in Alameda, California, and working on new cell lines he claimed would enable more efficient large-scale production.*The case is ABEC, Inc. v. Eat Just, Inc
Cultivated meat startup GOOD Meat has upped the ante in its increasingly ugly legal dispute with bioreactor specialist ABEC over alleged nonpayment of bills. GOOD has filed a series of counterclaims alleging that ABEC breached the terms of their contract and that GOOD Meat is in fact the wronged party. The litigation began in March 2023 when ABEC filed a lawsuit accusing GOOD Meat (a wholly owned subsidiary of Eat Just) of breach of contract by failing to pay its bills on time. ABEC, which had been working with GOOD Meat on pilot cultivated chicken facilities in California and Singapore, signed an agreement with the startup in August 2021. Under the seven-year deal, ABEC would design, manufacture, install and commission multiple 250,000-liter vessels— “the largest known bioreactors for avian and mammalian cell culture”—for a large-scale facility in the US with the capacity to produce up to 30 million pounds of meat
Eat Just—like Beyond Meat—is often seen as a proxy for the broader alternative protein space, regarded by some as a visionary foodtech pioneer attempting to disrupt two vast addressable markets (meat, eggs) and by other less charitable observers as a “house of cards built on one individual’s ability to separate people from their money.”. Regardless of where you sit on this spectrum, says one foodtech investor we spoke to this week, it would be “pretty catastrophic” for the category if either of these loss-making firms were to crash and burn, so a lot is riding on their performance in the coming months. So how should we view Eat Just, and can Tetrick—”one of the best capital-raisers in the business“— raise the funds to take cultivated meat from a loss-making novelty to a commercially viable alternative to animal agriculture?
Malcolm joins KPC from ABEC Inc, where he led the development of their European Services Business and contributed to their global capital project expansion.